Childhood infection and prevention of obesity

儿童感染与肥胖的预防

基本信息

  • 批准号:
    8539064
  • 负责人:
  • 金额:
    $ 70.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-25 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

Program Director/Principal Investigator (Last, First, Middle): Parsonnet, Julie ABSTRACT Obesity is epidemic in the U.S. with almost 20% of children considered obese. The dramatic rise in overweight and obesity over the last 40 years coincides with equally dramatic decreases in childhood infections. Although these inverse trends-rising obesity and declining infection-could be only coincidentally related, we postulate that the relationship is, in fact, causal. Infectious agents are the most intimate and constant exposure in human existence. This fact is brought to our attention annually as each year, new infectious agents are unexpectedly identified as causal factors in chronic disease. With respect to obesity, infections can both increase energy expenditure and decrease appetite through a variety of direct and indirect mechanisms. Infection-induced cytokines can also affect adipocyte differentiation, growth and lipolysis. Since these are all critical factors in human weight gain, it is axiomatic-though currently quite controversial-to assume that infections may reduce weight in U.S. children. We hypothesize that frequent, chronic and/or severe prenatal and childhood infection prevent weight gain, overweight and obesity in children. Secondarily, we will address the hypothesis that early acquisition of specific chronic infections-e.g.,herpesviruses and H. pylori infection-protect against obesity. We plan to test these hypotheses in a series of pilot studies, followed by a longitudinal cohort study that follows young children from conception through at least 5 years and, ultimately to adolescence and adulthood, to determine how infectious diseases shape body habitus. Determination of infection in children will rely on two interrelated exposure measures: monitoring and reporting of daily symptoms and signs by parents, and documentation of seroconversion to a large panel of microbes. We will also explore mechanisms by which infection might alter weight gain including effects on resting energy expenditure, circulating inflammatory cytokines, and adipocytokine levels. The discovery of H. pylori in the 1980's demonstrated how accepted paradigms of disease causation can be astonishingly wrong. For obvious reasons, the study of obesity (like the study of stomach cancer before 1990) has focused on food. Although we are not revolutionary enough to say that food is immaterial to weight, we do propose that a significant proportion of the increase in weight in U.S. children over the last 40 years is related not to bad habits but to healthy, uninfected lives. This idea-if proved trued-would certainly prove transformative, potentially changing overall conceptions of weight, health and disease in childhood.
项目总监/主要研究者(最后,第一,中间):Parsonnet,Julie 摘要 肥胖症在美国很流行,近20%的儿童被认为肥胖。在过去40年里,超重和肥胖症的急剧增加与儿童感染的急剧减少相吻合。尽管这些相反的趋势肥胖率上升和感染率下降可能只是巧合,但我们假设这种关系实际上是因果关系。传染性病原体是人类生存中最亲密和持续的暴露。这一事实每年都引起我们的注意,因为每年都有新的传染性病原体被意外地确定为慢性疾病的致病因素。关于肥胖,感染可以通过各种直接和间接机制增加能量消耗并降低食欲。 抑制诱导的细胞因子也可影响脂肪细胞分化、生长和脂解。由于这些都是人类体重增加的关键因素,因此假设感染可能会减轻美国儿童的体重是不言自明的,尽管目前相当有争议。 我们假设频繁、慢性和/或严重的产前和儿童期感染可预防儿童体重增加、超重和肥胖。其次,我们将讨论的假设,早期获得特定的慢性感染,疱疹病毒和H.幽门螺杆菌感染-预防肥胖。我们计划在一系列试点研究中测试这些假设,然后进行一项纵向队列研究,跟踪幼儿从受孕到至少5年,最终到青春期和成年期,以确定传染病如何塑造体型。儿童感染的确定将依赖于两个相互关联的暴露措施:监测和报告父母的日常症状和体征,以及记录大量微生物的血清转化。我们还将探讨感染可能改变 体重增加,包括对静息能量消耗、循环炎性细胞因子和脂肪细胞因子水平的影响。 H. 20世纪80年代的幽门螺旋杆菌感染证明了公认的疾病因果关系的范式是多么的错误。由于显而易见的原因,肥胖的研究(如1990年以前的胃癌研究)一直集中在食物上。虽然我们还没有革命性地说食物对体重是无关紧要的,但我们做到了 他认为,在过去40年里,美国儿童体重增加的很大一部分与不良习惯无关,而是与健康、未受感染的生活有关。这个想法如果被证明是正确的,肯定会被证明是变革性的,可能会改变儿童时期对体重、健康和疾病的整体观念。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gestational diabetes is driven by microbiota-induced inflammation months before diagnosis.
妊娠糖尿病是由诊断前微生物群引起的炎症驱动的。
  • DOI:
    10.1136/gutjnl-2022-328406
  • 发表时间:
    2023-05
  • 期刊:
  • 影响因子:
    24.5
  • 作者:
    Pinto, Yishay;Frishman, Sigal;Turjeman, Sondra;Eshel, Adi;Nuriel-Ohayon, Meital;Shrossel, Oshrit;Ziv, Oren;Walters, William;Parsonnet, Julie;Ley, Catherine;Johnson, Elizabeth L.;Kumar, Krithika;Schweitzer, Ron;Khatib, Soliman;Magzal, Faiga;Muller, Efrat;Tamir, Snait;Tenenbaum-Gavish, Kinneret;Rautava, Samuli;Salminen, Seppo;Isolauri, Erika;Yariv, Or;Peled, Yoav;Poran, Eran;Pardo, Joseph;Chen, Rony;Hod, Moshe;Borenstein, Elhanan;Ley, Ruth E.;Schwartz, Betty;Louzoun, Yoram;Hadar, Eran;Koren, Omry
  • 通讯作者:
    Koren, Omry
Longitudinal comparison of the developing gut virome in infants and their mothers.
  • DOI:
    10.1016/j.chom.2023.01.003
  • 发表时间:
    2023-02-08
  • 期刊:
  • 影响因子:
    30.3
  • 作者:
    Walters, William A.;Granados, Andrea C.;Ley, Catherine;Federman, Scot;Stryke, Doug;Santos, Yale;Haggerty, Thomas;Sotomayor-Gonzalez, Alicia;Servellita, Venice;Ley, Ruth E.;Parsonnet, Julie;Chiu, Charles Y.
  • 通讯作者:
    Chiu, Charles Y.
Urinary triclosan is associated with elevated body mass index in NHANES.
  • DOI:
    10.1371/journal.pone.0080057
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Lankester J;Patel C;Cullen MR;Ley C;Parsonnet J
  • 通讯作者:
    Parsonnet J
A modified Michaelis-Menten equation estimates growth from birth to 3 years in healthy babies in the USA.
A modified Michaelis-Menten equation estimates growth from birth to 3 years in healthy babies in the US.
修改后的 Michaelis-Menten 方程估计了美国健康婴儿从出生到 3 岁的生长情况。
  • DOI:
    10.21203/rs.3.rs-2375831/v2
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Walters,William;Ley,Catherine;Hastie,Trevor;Ley,Ruth;Parsonnet,Julie
  • 通讯作者:
    Parsonnet,Julie
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Julie Parsonnet其他文献

Julie Parsonnet的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Julie Parsonnet', 18)}}的其他基金

Feasibility of conducting HIV surveillance in community wastewater
在社区废水中进行艾滋病毒监测的可行性
  • 批准号:
    10762254
  • 财政年份:
    2023
  • 资助金额:
    $ 70.56万
  • 项目类别:
Longitudinal investigations of the infant virome and its associations with obesity
婴儿病毒组的纵向研究及其与肥胖的关系
  • 批准号:
    9564164
  • 财政年份:
    2017
  • 资助金额:
    $ 70.56万
  • 项目类别:
Household Triclosan and Triclocarban Use and the Developing Infant Microbiome
家庭三氯生和三氯卡班的使用与婴儿微生物群的发育
  • 批准号:
    8605752
  • 财政年份:
    2014
  • 资助金额:
    $ 70.56万
  • 项目类别:
Household Triclosan and Triclocarban Use and the Developing Infant Microbiome
家庭三氯生和三氯卡班的使用与婴儿微生物群的发育
  • 批准号:
    8791686
  • 财政年份:
    2014
  • 资助金额:
    $ 70.56万
  • 项目类别:
Household Triclosan and Triclocarban Use and the Developing Infant Microbiome
家庭三氯生和三氯卡班的使用与婴儿微生物群的发育
  • 批准号:
    8990838
  • 财政年份:
    2014
  • 资助金额:
    $ 70.56万
  • 项目类别:
Epidemiology of Helicobacter Pylori Transmission
幽门螺杆菌传播的流行病学
  • 批准号:
    8102528
  • 财政年份:
    2010
  • 资助金额:
    $ 70.56万
  • 项目类别:
Childhood infection and prevention of obesity
儿童感染与肥胖的预防
  • 批准号:
    8132442
  • 财政年份:
    2009
  • 资助金额:
    $ 70.56万
  • 项目类别:
Childhood infection and prevention of obesity
儿童感染与肥胖的预防
  • 批准号:
    7939719
  • 财政年份:
    2009
  • 资助金额:
    $ 70.56万
  • 项目类别:
Childhood infection and prevention of obesity
儿童感染与肥胖的预防
  • 批准号:
    8250240
  • 财政年份:
    2009
  • 资助金额:
    $ 70.56万
  • 项目类别:
Childhood infection and prevention of obesity
儿童感染与肥胖的预防
  • 批准号:
    8321437
  • 财政年份:
    2009
  • 资助金额:
    $ 70.56万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.56万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了